The mice model Industry is expected at USD 2.00 billion in 2027 from USD 1.22 billion in 2019, registering a CAGR of 6.8% through the forecast period, according to a current report by Emergen Research. During the forecast period, due to the growing demand for humanised mice prototypes, the global mice model market is expected to grow significantly.
The growing use of mice models in virology and infectious disease studies is expected to further propel the global demand for mice models during the forecast period. In addition, growing adoption by contract research organisations (CROs) of mice models for clinical research is expected to raise the global demand for mice models in the near future.
However, growing objections from many organizations on mouse research are expected to hinder the global mice model market to some degree during the forecast period.
For More Details Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/457
The report further emphasizes the developmental strategies undertaken by these companies, including product innovation, new product launches, and technological upgradation. Moreover, the report studies the notable business events observed in this industry, such as mergers & acquisitions, joint ventures, partnerships, corporate deals, and brand promotions.
Key market participants include Envigo Ltd, TransViragen Inc., Charles River Laboratories International Inc., GenOway S.A., The Jackson Laboratory, Ozgene Pty Ltd, GVK Biosciences Private Limited, Taconic Biosciences Inc., Pharmaron, Inc., and Horizon Discovery Group plc.
To get leading market solutions, visit the link below:
Mice Model Market Solution Insights:
The CRISPR sub-segment is expected to lead the market during the forecast period due to the reliability and versatility of CRISPR technology. CRISPR reduces the time needed to alter target genes so that they can be easily applied to embryos, in comparison to gene targeting methods focused on the use of embryonic stem cells.
The pharmaceutical segment is expected to lead the market over the forecast period due to the rising use of the mice model for drug production and veterinary testing purposes.
During the forecast period, due to the presence of major market players and the increase in biomedical studies in this area, the North American region is projected to lead the global market.
More Insights on this report, Speak to Our Analyst: https://www.emergenresearch.com/purchase-enquiry-form/457
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Mice Model Market Segmentation & Impact Analysis
4.1. Mice Model Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
22.214.171.124. Increasing demand of humanized mice prototypes
126.96.36.199. The increasing use of models of mice in virology and contagious diseases
188.8.131.52. Increasing investment in research and development activities in the pharmaceutical & biotechnology sector
184.108.40.206. The increasing utilization of mice model for personalized drugs production
4.2.3. Market restraints analysis
220.127.116.11. Continuous discovery in substitute approaches for animal studies
18.104.22.168. Rising objections by many organizations against mouse testing
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Mice Model Market By Type Insights & Trends Revenue (USD Billion)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.5. Spontaneous Mutant
Chapter 6. Mice Model Market By Service Insights & Trends Revenue (USD Billion)
6.1. Service Dynamics & Market Share, 2019 & 2027
6.1.3. Genetic Testing
Chapter 7. Mice Model Market By Technology Insights & Trends Revenue (USD Billion)
7.1. Technology Dynamics & Market Share, 2019 & 2027
7.1.2. Nuclear Transfer
7.1.3. Embryonic Stem cell Injection
Directly Purchase/Place an Order for a copy of this research report at https://www.emergenresearch.com/select-license/457